NVO - NOVO NORDISK A S

QQQ $ 481.89 $ -2.28 (-0.47 %)

DIA $ 408.64 $ -1.80 (-0.44 %)

SPY $ 560.34 $ -2.07 (-0.37 %)

TLT $ 97.64 $ -0.57 (-0.59 %)

GLD $ 228.93 $ -1.34 (-0.58 %)

Previous Close

$ 134.96

Open

$ 137.38

Bid

$ 137.24 x 100

Ask

$ 137.27 x 100

Day's Range

$ 137.01 - $ 138.44

52 Week Range

$ 86.02 - $ 147.60

Volume

2,410,507

Average Volume

Market Cap

608,670

Beta (5Y Monthly)

$ 0.66

PE Ratio (TTM)

$ 0.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

wegovy-now-available-through-sesames-249-monthly-compounded-program-despite-supply-shortages

Wegovy Now Available Through Sesame's $249...
08/21/2024 15:44:23

Sesame introduces an affordable weight loss program with compounded versions of Wegovy amid supply shortages. The program provi...

novo-nordisk-vs-eli-lilly-beyond-the-weight-loss-drug-battle

Novo Nordisk Vs. Eli Lilly: Beyond The Wei...
08/21/2024 12:51:04

Novo Nordisk and Eli Lilly are competing for the obesity-drug market, but their growth plans extend beyond weight-loss treatmen...

ozempic-and-wegovy-linked-to-increased-suicidal-thoughts-in-observational-study-but-results-are-contested

Ozempic And Wegovy Linked to Increased Sui...
08/20/2024 18:06:17

A recent study in JAMA Network Open raises concerns about a potential link between GLP-1 drugs Ozempic and Wegovy and an increa...

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-5900-today

If You Invested $1000 In This Stock 10 Yea...
08/20/2024 18:00:13

nsa-code-breaker-jim-simons-hedge-fund-renaissance-technologies--ozempic-wegovy-maker-novo-nordisk-along-with-nvidia-palantir-among-top-holdings

NSA Code Breaker Jim Simons' Hedge Fund Re...
08/20/2024 02:25:30

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently di...

A Glimpse Into The Expert Outlook On Novo ...
08/19/2024 20:00:16

Cantor Fitzgerald Reiterates Overweight on...
08/19/2024 16:26:46

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

telehealth-firm-hims--hers-health-rides-high-on-demand-for-copycat-weight-loss-drugs-amid-supply-shortages

Telehealth Firm Hims & Hers Health Rides H...
08/19/2024 13:24:02

Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss ...

doctors-struggle-to-secure-medicare-coverage-for-heart-patients-on-novo-nordisks-wegovy

Doctors Struggle to Secure Medicare Covera...
08/16/2024 17:59:37

Medicare patients struggle to access Novo Nordisk's Wegovy for heart disease treatment despite new guidelines, with many pl...

roche-misses-out-on-weight-loss-blockbuster-drug-now-playing-catch-up-in-booming-market

Roche Misses Out On Weight-Loss Blockbuste...
08/16/2024 17:56:16

Roche missed out on acquiring a potential blockbuster weight-loss drug, now owned by Eli Lilly, in 2018. The drug, orforglipron...

unpacking-the-latest-options-trading-trends-in-novo-nordisk

Unpacking the Latest Options Trading Trend...
08/15/2024 15:46:18

dont-promote-copycat-weight-loss-drugs-amid-improved-supply-eli-lilly-asks-doctors-fda-evaluates

Don't Promote Copycat Weight-Loss Drugs Am...
08/14/2024 18:35:14

Eli Lilly issues cease-and-desist letters to healthcare providers, demanding they stop promoting compounded weight-loss drugs a...

eli-lilly-smashed-estimates-thanks-to-unbelievable-demand-for-its-diabetes-and-weight-loss-blockbusters

Eli Lilly Smashed Estimates Thanks To Unbe...
08/14/2024 14:26:17

On Thursday, Eli Lilly and Company (NYSE: LLY) reported its second quarter results, smashing estimates fueled by the popularity...

weight-loss-drugs-like-ozempic-zepbound-may-reduce-cancer-risks-studies-suggest

Weight Loss Drugs Like Ozempic, Zepbound M...
08/12/2024 17:37:30

GLP-1 agonists like Ozempic and Wegovy, known for treating obesity and diabetes, are now showing potential in reducing cancer r...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
08/12/2024 17:35:22

eli-lillys-q2-sales-surge-36-analysts-cautious-on-future-supply-market-dynamics-optimistic-about-next-gen-oral-weight-loss-drug

Eli Lilly's Q2 Sales Surge 36%, Analysts C...
08/09/2024 20:03:04

Eli Lilly's Q2 revenue soared to $11.3 billion, surpassing forecasts. Mounjaro sales tripled and Zepbound revenue grew sign...

BMO Capital Maintains Outperform on Novo N...
08/08/2024 15:52:44

BMO Capital analyst Evan David Seigerman maintains Novo Nordisk (NYSE:NVO) with a Outperform and lowers the price target fro...

Lilly Executive Says Concord Manufacturing...
08/08/2024 14:52:15

Conference Call

novo-nordisk-withdraws-wegovy-fda-heart-failure-submission-terminates-development-of-two-early-stage-assets

Novo Nordisk Withdraws Wegovy FDA Heart Fa...
08/07/2024 17:55:16

Novo Nordisk missed Q2 earnings estimates and announced plans to resubmit Wegovy STEP HFpEF trial results for FDA review in ear...

wall-street-poised-for-second-day-of-gains-while-bank-of-japan-makes-reassurances-dollar-strengthens-against-yen-crude-prices-surge-whats-driving-markets-wednesday

Wall Street Poised For Second Day Of Gains...
08/07/2024 16:46:55

The U.S.